Digital On-Demand Conference
ACCREDITATION STATEMENT
This activity has been approved for 25 AMA PRA Category 1 Credits
AMA PRA Category 1 Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Foundation for Care Management (FCM) and Age Management Medicine Group. The Foundation for Care Management is accredited by the ACCME to provide continuing medical education for physicians.
FCM designates this educational activity for a maximum of 25 AMA PRA Category 1 CreditsTM.
Physicians should only claim credit commensurate with the extent of their participation in this activity.
The ACCME defines a “Commercial Interest” as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Nursing Statement
The Foundation for Care Management is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. 25 Nursing contact hour(s).
The Foundation for Care Management is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Program # 0347-9999-20-010-H01-P Objectives appropriate for pharmacists. This activity is 25 Contact Hours Pharmacy Credit. *This CME is Knowledge Based (k). Initial release November 2, 2020.
Course OBJECTIVES
- Compare essential scientific evidence-based information on core aspects of Age Management Medicine, such areas as hormone replacement for men and women, nutrition and supplements, fitness, and patient assessment protocols to provide for superior patient outcomes.
- Describe the essential scientific evidence-based information for the use of approved Hormones in Age Management Medicine and how to clinically apply this knowledge to individualized patient treatment plans to improve patient outcomes.
- Discuss new scientific evidence-based information for disease prevention and intervention, specifically for Covid-19 and how to clinically apply this knowledge to individualized patient treatment plans to improve patient outcomes.
- Explain evidence-based information on Precision Medicine applications such as Senolytics, Gene Therapy and a Systems Approach to Age Rejuvenation.
- Recall scientific information on Cannabis Metabolomics and the Dangers of Vaping as it pertains to improving patient outcomes.
- Define scientific information on a range of additional topics in Age Management Medicine such as Traumatic Brain Injury, fungicides & Mycotoxins, Hyperbaric Oxygen for Neurological injury and treatment of SIBO Cases
CONFERENCE PLANNING COMMITTEE — DISCLOSURES
Mary L. Corry, R.N. — No Relevant Relationships with a Commercial Interest to Disclose
Mark L. Gordon, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
Edwin Lee, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
Rob A. Kominiarek, D.O. — No Relevant Relationships with a Commercial Interest to Disclose
Cesar M. Pellerano, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
John Rush, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
George Shapiro, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
No member of The Foundation for Care Management or the Age Management Medicine Group has any relevant financial relationships to disclose in regards to this activity.
FACULTY — DISCLOSURES
Michaele Barber, M.D. — No relevant commercial interest or financial relationship to disclose
Louis B. Cady, M.D. — No relevant commercial interest or financial relationship to disclose
Andrew Campbell, M.D. — No relevant commercial interest or financial relationship to disclose
William Clearfield, D.O. — No relevant commercial interest or financial relationship to disclose
Mary Corry, R.N. — No relevant commercial interest or financial relationship to disclose
Angela DeRosa, D.O. — No relevant commercial interest or financial relationship to disclose
Derrick DeSilva, Jr. M.D. — No relevant commercial interest or financial relationship to disclose
Elliot Dinetz, M.D. — No relevant commercial interest or financial relationship to disclose
Mark L. Gordon, M.D. — No relevant commercial interest or financial relationship to disclose
Joseph Greco, Ph.D. — Advisory Committee-New Life Regenerative Medicine
Chris A. Kleronomos, FNP — No relevant commercial interest or financial relationship to disclose
Robert Kominiarek, D.O. — No relevant commercial interest or financial relationship to disclose
Edwin N. Lee, M.D., FACE — No relevant commercial interest or financial relationship to disclose
Luis Martinez, M.D., MPH — No relevant commercial interest or financial relationship to disclose
Michele Neil-Sherwood, D.O. — No relevant commercial interest or financial relationship to disclose
Rachna Patel. M.D. — No relevant commercial interest or financial relationship to disclose
Cesar M. Pellerano, M.D. — No relevant commercial interest or financial relationship to disclose
Kathryn Retzler, N.D. — No relevant commercial interest or financial relationship to disclose
David Rosensweet, M.D. — Owner & Founder-The Menopause Method
Neal Rouzier, M.D. — Speakers Bureau-Evexias
Mark Sherwood, N.D. — No relevant commercial interest or financial relationship to disclose
Eugene Shippen, M.D. — No relevant commercial interest or financial relationship to disclose
Daniel Stickler, M.D. — No relevant commercial interest or financial relationship to disclose
Jordan Tishler, M.D. — No relevant commercial interest or financial relationship to disclose
Dushyant Viswanathan, M.D. — No relevant commercial interest or financial relationship to disclose
Betty Wedman-St. Louis, PhD — No relevant commercial interest or financial relationship to disclose
Paul D. Werner, Esq. — No relevant commercial interest or financial relationship to disclose